搜索结果: 1-11 共查到“肿瘤治疗学 tumor”相关记录11条 . 查询时间(0.046 秒)
How A Tumor Grows Can Predict Response To Cancer Therapy（图）
Tumor Grows Predict Response Cancer Therapy
2018/1/10
Individual tumors respond differently to cancer drugs, if at all. Until now, it remained a mystery why tumors have different reactions to the exact same therapy. But a new study at the USC Viterbi Sch...
2017肿瘤代谢 Keystone Symposia（2017 Keystone Symposia on Tumor Metabolism: Mechanisms and Targets）
2-Oxoglutarate-Dependent Dioxygenases Cancer
2017/1/13
The meeting will begin on Sunday, March 5 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, March 9 with a closing plenary session ...
2016第26届肿瘤治疗和检测光学方法研讨会（Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVI）
2016 第26届 肿瘤治疗和检测光学方法 研讨会
2017/1/12
BiOS is organized into six tracks. Choose a track and click to see the list of conferences.Review conference details by clicking on the titles below. These details include paper titles, authors, sched...
Prolonged Survival of a Patient With Pelvic Recurrence of Ovarian Malignant Mixed Mullerian Tumor After Chemoradiotherapy
Mixed Tumor Mullerian Cytoreductive Surgery Chemoradiotherapy Chemotherapy Ovary
2015/10/14
Introduction: Malignant Mixed Mullerian Tumor (MMMT) is a very rare tumor, accounting for less than 1% of all ovarian cancers.
CD4+ T cell mediated tumor immunity following transplantation of TRP-1 TCR gene modified hematopoietic stem cells
Melanocyte Differentiation Antigen Lentiviral Vectors
2015/5/21
Immunotherapy for cancer has held much promise as a potent modality of cancer treatment. The ability to selectively destroy diseased cells and leave healthy cells unharmed has been the goal of cancer ...
Neuroectodermal tumor (A case report)
Primitive peripheral malignant neuroectodermal tumor case report
2010/1/5
Primitive Peripheral Malignant Neuroectodermal Tumor is a malignant neoplasm of neural origin with high mortality which occurs mostly in children and adolescents. The most common site of involvements ...
Tumor mutations can predict chemo success--Genetic profiling of tumors could have 'immediate impact' on treating cancer, study shows
tumor mutations chemo success immediate impact cancer
2009/8/10
New work by MIT cancer biologists shows that the interplay between two key genes that are often defective in tumors determines how cancer cells respond to chemotherapy.The findings should have an imme...
Current status of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) targeting cancer therapy
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) TRAIL receptor 1 (TRAIL-R1), TRAIL receptor 2 (TRAIL-R2) apoptosis KM mouseTM monoclonal antibody targeting therapeutics
2009/7/15
Monoclonal antibodies have already established a secure position as a very promising strategy for anti-tumor therapeutics. High specificity and high affinity are attractive characteristics of antibodi...
A FNAC Case of Metastatic Cystic Papillary Carcinoma of the Thyroid Simulating Parotid Tumor
Papillary Carcinoma Parotid Tumor
2009/7/3
Although fine needle aspiration cytopathology (FNAC) is now widely being used to diagnose many pathological lesions it was recently started in our university teaching hospital, which is a 10 year old ...
Tumor Necrosis Factor-a and Interleukin-6 in Peritoneal Adhesion Formation
Peritoneal adhesion Tumor necrosis factor-a Interleukin-6
2009/7/2
This study was carried out to assess the role of tumor necrosis factor (TNF-a) and interleukin-6 (IL-6 ) in plasma and peritoneal fluid in higher rates of adhesion formation following standard bowel i...
ANTI-TUMOR AND RADIO-SENSITIZING PROPERTIES OF AD-IU2, A PROSTATE-SPECIFIC REPLICATION-COMPETENT ADENOVIRUS ARMED WITH TRAIL
PSES Gene Therapy Ad-IU2 Adenovirus
2015/5/21
In this thesis, I investigated the preclinical utility and antitumor efficacy of TRAIL delivered by Ad-IU2, a prostate-specific replication-competent adenovirus (PSRCA), against androgen-independent p...